The European Medicines Agency's scientific guidelines on nanomedicines help medicine developers prepare marketing authorisation applications for human medicines.
For a complete list of scientific guidelines currently open for consultation, see Public consultations.
- Data requirements for intravenous iron-based nano-colloidal products developed with reference to an innovator medicinal product
- Data requirements for intravenous liposomal products developed with reference to an innovator liposomal product
- Development of block-copolymer-micelle medicinal products
- Surface coatings: general issues for consideration regarding parenteral administration of coated nanomedicine products